Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00587639 · ClinicalTrials.gov registry record · NA

An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

A NA study of Depression, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
8
Enrollment target
3
Study locations

NCT00587639: Completed NA study of Depression, sponsored by Mayo Clinic.

NCT00587639 is a NA study of Depression that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00587639, a NA study of Depression, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
3
Study locations

Study Summary

The objective of this investigation is to examine the safety and feasibility of a series of repetitive transcranial magnetic stimulation (rTMS) treatments (10 Hertz \[Hz\]; Left Dorsolateral Prefrontal Cortex), with a Neuronetics Model 2100 Therapy System as adjuvant treatment for depression in adolescent subjects.

Primary Outcome

The Children's Auditory Verbal Learning Test 2 (CAVLT-2) is a neuropsychological test that measures auditory verbal learning and memory. This test is designed for ages 6.6-17.11 years. Scores are reported as normalized standard scores. The minimum standard score is 60 and the maximum 140; a higher score indicates a better performance.

Conditions Studied

Depression

Interventions

  • DEVICE rTMS Treatment

Study Locations (3)

Illinois

  • Rush University - Chicago

Minnesota

  • Mayo Clinic - Rochester

Texas

  • University of Texas Southwestern - Dallas

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2007-05
Est. Completion 2009-10
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT00587639 record still lists

NCT00587639 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which rTMS Treatment is the first listed.

NCT00587639 reports a single indexed study location in Illinois, Minnesota, Texas.

Frequently Asked Questions

What is clinical trial NCT00587639 about?

NCT00587639 is a clinical study titled "An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression". The objective of this investigation is to examine the safety and feasibility of a series of repetitive transcranial magnetic stimulation (rTMS) treatments (10 Hertz \[Hz\]; Left Dorsolateral Prefrontal Cortex), with a Neuronetics Model 2100 Therapy System as adjuvant treatment for depression in adol...

What is the current status of trial NCT00587639?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2007-05. Estimated completion is 2009-10.

What conditions does trial NCT00587639 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00587639?

The interventions under investigation include: rTMS Treatment (DEVICE).

Who is sponsoring clinical trial NCT00587639?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00587639 being conducted?

This trial has 3 study locations across Illinois, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00587639's enrollment target sits among peer trials

8 667th of 679 higher than 10 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00587639, the US trial registry maintained by the National Library of Medicine. NCT00587639 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.